Travere Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,961	3,474	1,523	678	1,352	1,940
Market Cap Growth	114.83%	128.05%	124.84%	-49.89%	-30.30%	36.22%
Enterprise Value	4,024	3,474	1,480	510.57	1,305	1,645
Last Close Price	42.59	38.21	17.42	8.99	21.03	31.04
PE Ratio	-	-131.76	-4.27	-5.99	-4.81	-10.31
Forward PE	16.51	38.08	-	-	-	-
PS Ratio	7.39	7.08	6.53	4.67	12.35	14.71
PB Ratio	39.86	30.26	25.79	3.37	31.55	6.42
P/TBV Ratio	40.31	29.69	23.26	3.33	31.29	6.15
P/FCF Ratio	99.98	91.95	-6.42	-2.42	-7.26	-97.51
P/OCF Ratio	99.98	91.95	-6.42	-2.42	-7.26	-131.13
EV/Sales Ratio	7.50	7.08	6.35	3.52	11.92	12.48
EV/EBITDA Ratio	250.10	-1669.50	-5.28	-1.46	-4.36	-8.81
EV/EBIT Ratio	-	-55.30	-4.57	-1.32	-4.08	-8.25
EV/FCF Ratio	101.57	91.95	-6.23	-1.82	-7.00	-82.69
Debt / Equity Ratio	3.26	2.81	5.54	1.99	9.41	0.85
Debt / EBITDA Ratio	20.36	-157.97	-1.43	-1.16	-1.36	-1.40
Debt / FCF Ratio	8.30	8.70	-1.69	-1.45	-2.19	-13.17
Net Debt / Equity Ratio	0.64	0.05	0.52	-0.81	-1.00	-0.96
Net Debt / EBITDA Ratio	3.91	-2.85	-0.11	0.46	0.14	1.56
Net Debt / FCF Ratio	1.60	0.16	-0.13	0.58	0.23	14.62
Asset Turnover	0.92	0.82	0.34	0.20	0.15	0.19
Inventory Turnover	0.25	0.31	0.23	0.64	0.75	0.51
Quick Ratio	2.81	2.52	1.98	3.31	3.28	4.58
Current Ratio	3.13	2.74	2.08	3.47	3.42	4.70
Return on Equity (ROE)	-43.20%	-57.80%	-246.75%	-308.90%	-192.18%	-84.66%
Return on Assets (ROA)	-10.02%	-10.69%	-46.85%	-53.15%	-44.18%	-28.87%
Return on Invested Capital (ROIC)	-38.13%	-52.22%	-369.68%	-455.02%	-263.76%	-128.76%
Return on Capital Employed (ROCE)	-13.04%	-14.98%	-64.48%	-68.01%	-54.07%	-34.17%
Earnings Yield	-0.54%	-0.76%	-23.42%	-16.69%	-20.78%	-9.70%
FCF Yield	1.00%	1.09%	-15.59%	-41.33%	-13.78%	-1.03%
Buyback Yield / Dilution	-10.28%	-13.09%	-6.22%	-16.48%	-6.56%	-25.86%
Total Shareholder Return	-10.28%	-13.09%	-6.22%	-16.48%	-6.56%	-25.86%

Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q